Anti-GM-CSF Monoclonal Antibody Gimsilumab for COVID-19 Pneumonia: A Randomized, Double-Blind, Placebo-Controlled Trial
American Journal of Respiratory and Critical Care Medicine (2022) - Comments
doi: 10.1164/rccm.202108-1859oc  issn: 1073-449x  issn: 1535-4970  pubmed: 35290169 

Gerard J. Criner, Frederick M. Lang, Robert L Gottlieb, Kusum S Mathews, Tisha S. Wang, Todd W Rice, Deepu Madduri, Shashi Bellam, Robert Jeanfreau, Amy H. Case, Marilyn K Glassberg, George M. Lyon, Kareem Ahmad, Robert Mendelson, J. Michael DiMaio, MaryAnn P. Tran, Cedric W. Spak, Jamil A. Abbasi, Steven G. Davis, Shekhar Ghamande